These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6230805)

  • 1. Isolation and fast purification of neocarzinostatin by FPLC-ion exchange chromatography.
    Denklau D; Köhnlein W; Lüders G; Stellmach J
    Z Naturforsch C Biosci; 1983; 38(11-12):939-42. PubMed ID: 6230805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A facile method of purification of neocarzinostatin, an antitumor protein.
    Samy TS; Hu JM; Meienhofer J; Lazarus H; Johnson RK
    J Natl Cancer Inst; 1977 Jun; 58(6):1765-8. PubMed ID: 140942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neocarzinostatin chromophore: purification of the major active form and characterization of its spectral and biological properties.
    Napier MA; Holmquist B; Strydom DJ; Goldberg IH
    Biochemistry; 1981 Sep; 20(19):5602-8. PubMed ID: 6457635
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of a free chromophore component of neocarzinostatin (NCS) in the culture filtrate of Streptomyces carzinostaticus var. F-41.
    Kudo K; Suto T; Koide Y; Edo K; Ishida N
    J Antibiot (Tokyo); 1982 Aug; 35(8):1111-5. PubMed ID: 6216232
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibitory mechanism of in vitro protein phosphorylation by a nonprotein chromophore removed from neocarzinostatin.
    Ohtsuki K; Sato T; Koike T; Koyama K; Ishida N
    Biochim Biophys Acta; 1981 Mar; 673(2):147-56. PubMed ID: 6260230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neocarzinostatin: carboxyl-terminal-43-peptide residue of apo-neocarzinostatin as the binding site of neocarzinostatin-chromophore.
    Edo K; Saito K; Akiyama Y; Mizugaki M; Koide Y; Ishida N
    Chem Pharm Bull (Tokyo); 1986 Dec; 34(12):5180-3. PubMed ID: 2952300
    [No Abstract]   [Full Text] [Related]  

  • 7. Solution structure of a novel chromoprotein derived from apo-neocarzinostatin and a synthetic chromophore.
    Urbaniak MD; Muskett FW; Finucane MD; Caddick S; Woolfson DN
    Biochemistry; 2002 Oct; 41(39):11731-9. PubMed ID: 12269815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the antitumor protein neocarzinostatin. Purification, amino acid composition, disulfide reduction, and isolation and composition of tryptic peptides.
    Maeda H; Glaser CB; Czombos J; Meienhoffer J
    Arch Biochem Biophys; 1974 Oct; 164(2):369-78. PubMed ID: 4282218
    [No Abstract]   [Full Text] [Related]  

  • 9. Proton NMR studies of apo-neocarzinostatin from Streptomyces carzinostaticus. Sequence-specific assignment and secondary structure.
    Adjadj E; Mispelter J; Quiniou E; Dimicoli JL; Favaudon V; Lhoste JM
    Eur J Biochem; 1990 Jun; 190(2):263-71. PubMed ID: 2142075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of the nonprotein chromophore of neocarzinostatin to deoxyribonucleic acid.
    Povirk LF; Goldberg IH
    Biochemistry; 1980 Oct; 19(21):4773-80. PubMed ID: 6448634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reexamination of the primary structure of an antitumor protein, neocarzinostatin.
    Kuromizu K; Tsunasawa S; Maeda H; Abe O; Sakiyama F
    Arch Biochem Biophys; 1986 Apr; 246(1):199-205. PubMed ID: 2938543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activities and physicochemical properties of pre-neocarzinostatin and UV-irradiated neocarzinostatin.
    Iseki S; Koide Y; Ebina T; Ishida N
    J Antibiot (Tokyo); 1980 Jan; 33(1):110-3. PubMed ID: 6445350
    [No Abstract]   [Full Text] [Related]  

  • 13. Trioxacarcins, novel antitumor antibiotics. II. Isolation, physico-chemical properties and mode of action.
    Tamaoki T; Shirahata K; Iida T; Tomita F
    J Antibiot (Tokyo); 1981 Dec; 34(12):1525-30. PubMed ID: 6800996
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of epoxide in neocarzinostatin chromophore stability and action.
    Lee SH; Goldberg IH
    Mol Pharmacol; 1988 Apr; 33(4):396-401. PubMed ID: 2965788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of HeLa cell chromatin by neocarzinostatin and its chromophore.
    McHugh MM; Woynarowski J; Beerman T
    Biochim Biophys Acta; 1982 Jan; 696(1):7-14. PubMed ID: 6211192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-neocarzinostatin, a specific antagonist of neocarzinostatin.
    Kikuchi M; Shoji M; Ishida N
    J Antibiot (Tokyo); 1974 Oct; 27(10):766-74. PubMed ID: 4281770
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of neocarzinostatin chromophore-deoxyribose adducts as exonuclease-resistant sites in defined-sequence DNA.
    Povirk LF; Goldberg IH
    Biochemistry; 1985 Jul; 24(15):4035-40. PubMed ID: 2996589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urea treatment and pronase digestion of antitumor protein antibiotics, auromomycin and neocarzinostatin.
    Suzuki H; Ozawa S; Tanaka N
    J Antibiot (Tokyo); 1980 Dec; 33(12):1545-50. PubMed ID: 6454671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of actions of neocarzinostatin (NCS) and NCS-associated nonprotein chromophore (author's transl)].
    Ohtsuki K; Ishida N
    Tanpakushitsu Kakusan Koso; 1981 Jun; 26(7):937-49. PubMed ID: 6457319
    [No Abstract]   [Full Text] [Related]  

  • 20. New metabolites, tetrahydrofuran lignans, produced by Streptomyces sp. IT-44.
    Chiung YM; Hayashi H; Matsumoto H; Otani T; Yoshida K; Huang MY; Chen RX; Liu JR; Nakayama M
    J Antibiot (Tokyo); 1994 Apr; 47(4):487-91. PubMed ID: 8195049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.